Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Am Chem Soc ; 146(22): 15085-15095, 2024 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-38776232

RESUMEN

The spleen emerges as a pivotal target for mRNA delivery, prompting a continual quest for specialized and efficient lipid nanoparticles (LNPs) designed to enhance spleen-selective transfection efficiency. Here we report imidazole-containing ionizable lipids (IMILs) that demonstrate a pronounced preference for mRNA delivery into the spleen with exceptional transfection efficiency. We optimized IMIL structures by constructing and screening a multidimensional IMIL library containing multiple heads, tails, and linkers to perform a structure-activity correlation analysis. Following high-throughput in vivo screening, we identified A3B7C2 as a top-performing IMIL in spleen-specific mRNA delivery via the formulated LNPs, achieving a remarkable 98% proportion of splenic transfection. Moreover, A3B7C2-based LNPs are particularly potent in splenic dendritic cell transfection. Comparative analyses revealed that A3B7C2-based LNPs achieved a notable 2.8-fold and 12.9-fold increase in splenic mRNA transfection compared to SM102 and DLin-MC3-DMA lipid formulations, respectively. Additionally, our approach yielded an 18.3-fold enhancement in splenic mRNA expression compared to the SORT method without introducing additional anionic lipids. Collectively, these IMILs highlight promising avenues for further research in spleen-selective mRNA delivery. This work offers valuable insights for the swift discovery and rational design of ionizable lipid candidates tailored for spleen-selective transfection, thereby facilitating the application of mRNA therapeutics in spleen-related interventions.


Asunto(s)
Imidazoles , Lípidos , ARN Mensajero , Bazo , Bazo/metabolismo , Imidazoles/química , Lípidos/química , Lípidos/síntesis química , ARN Mensajero/administración & dosificación , ARN Mensajero/genética , Animales , Ratones , Transfección/métodos , Nanopartículas/química , Estructura Molecular
2.
Small ; 20(10): e2305131, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37875640

RESUMEN

Protein drugs hold promise in treating multiple complex diseases, including cancer. The priority of protein drug application is precise delivery of substantial bioactive protein into tumor site. Metal-organic-framework (MOF) is widely considered as a promising carrier to encapsulate protein drug owing to the noncovalent interaction between carrier and protein. However, limited loading efficiency and potential toxicity of metal ion in MOF restrict its application in clinical research. Herein, a tumor targeted collagenase-encapsulating MOF via protein-metal ion-organic ligand coordination (PMOCol ) for refining deep tissue pancreatic cancer photoimmunotherapy is developed. By an expedient method in which the ratio of metal ion, histidine residues of protein and ligand is precisely controlled, PMOCol is constructed with ultrahigh encapsulation efficiency (80.3 wt%) and can release collagenase with high enzymatic activity for tumor extracellular matrix (ECM) regulation after reaching tumor microenvironment (TME). Moreover, PMOcol exhibits intensively poorer toxicity than the zeolitic imidazolate framework-8 biomineralized protein. After treatment, the pancreatic tumor with abundant ECM shows enhanced immunocyte infiltration owing to extracellular matrix degradation that improves suppressive TME. By integrating hyperthermia agent with strong near-infrared absorption (1064 nm), PMOCol can induce acute immunogenicity to host immunity activation and systemic immune memory production to prevent tumor development and recurrence.


Asunto(s)
Estructuras Metalorgánicas , Neoplasias Pancreáticas , Humanos , Estructuras Metalorgánicas/química , Ligandos , Proteínas , Neoplasias Pancreáticas/terapia , Colagenasas , Microambiente Tumoral
3.
J Org Chem ; 87(6): 4051-4060, 2022 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-35201777

RESUMEN

The palladium-catalyzed three-component alkoxyarylation reaction of [60]fullerene with primary/secondary alcohols and aryl iodides generates a series of 1,4-(alkoxy)(aryl)[60]fullerene derivatives. Plausible reaction pathways for the formation of 1,4-(alkoxy)(aryl)[60]fullerenes are proposed. In addition, the electrochemical properties of the synthesized 1,4-alkoxyarylation adducts are investigated.

4.
Nano Lett ; 20(1): 242-251, 2020 01 08.
Artículo en Inglés | MEDLINE | ID: mdl-31790598

RESUMEN

Myeloid-derived suppressor cells (MDSCs) promote tumor immune escape through multiple mechanisms including suppressing antitumor activities of T lymphocytes. However, therapeutic abrogation of MDSCs often causes severe adverse effects, compensatory recruitment of alternative cell populations, and the multiplicity and complexity of relevant cytokines/receptors. Alternatively, suppressing the expansion and tumor trafficking of MDSCs may be a proficient and safe way for cancer treatment. Here we report that pseudoneutrophil cytokine sponges (pCSs) can disrupt expansion and tumor trafficking of MDSCs and reverse immune tolerance. Coated with plasma membranes of neutrophils phenotypically and morphologically similar to polymorphonuclear MDSCs (PMN-MDSCs), the nanosized pCSs inherited most membrane receptors from the "parental" neutrophils, enabling the neutralization of MDSC-related cytokines. Upon pCSs administration, the expansion of MDSCs and their enrichment in peripheral lymphoid organs and tumors were reduced without the compensatory influx of alternative myeloid subsets. In murine breast cancer and melanoma syngeneic models, pCSs treatment dramatically increased the number of tumor-infiltrating T lymphocytes and restored their antitumor functions. In addition, when pCSs were combined with the programmed cell death protein 1 (PD-1), the immune checkpoint blockade synergistically suppressed tumor progression and prolonged animal survival. Overall, the pseudocell nanoplatform opens up new paths toward effective cancer immunotherapy.


Asunto(s)
Citocinas , Inmunoterapia , Neoplasias Mamarias Experimentales , Melanoma Experimental , Neutrófilos/inmunología , Animales , Línea Celular Tumoral , Citocinas/inmunología , Citocinas/farmacología , Implantes de Medicamentos/farmacología , Femenino , Neoplasias Mamarias Experimentales/inmunología , Neoplasias Mamarias Experimentales/patología , Neoplasias Mamarias Experimentales/terapia , Melanoma Experimental/inmunología , Melanoma Experimental/patología , Melanoma Experimental/terapia , Ratones , Ratones Endogámicos ICR , Células Supresoras de Origen Mieloide/inmunología , Células Supresoras de Origen Mieloide/patología , Neutrófilos/patología , Receptor de Muerte Celular Programada 1/inmunología
5.
Chem Commun (Camb) ; 51(30): 6548-51, 2015 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-25766768

RESUMEN

A cuprous bromide-catalyzed heteroannulation reaction of [60]fullerene with ketoxime acetates has been exploited to prepare novel 1-fulleropyrrolines through the cleavage of N-O and C-H bonds and formation of C-C and C-N bonds under thermal conditions. A plausible mechanism for the formation of 1-fulleropyrrolines is proposed on the basis of the experimental results. The electrochemistry of the obtained products has also been investigated.

6.
Org Lett ; 15(13): 3408-11, 2013 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-23773112

RESUMEN

The FeCl3-mediated reaction of [60]fullerene with N-benzhydryl sulfonamides afforded C60-fused indane derivatives using the high-speed vibration milling technique. A possible reaction mechanism involving the unprecedented FeCl3-mediated homolytic C-N bond cleavage of N-benzhydryl sulfonamides is proposed. The electrochemistry of the obtained C60-fused indanes was also investigated.

7.
Chem Commun (Camb) ; 48(65): 8132-4, 2012 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-22773035

RESUMEN

The palladium-catalysed heteroannulation of [60]fullerene with various N-benzyl sulfonamides via C-H bond activation affords [60]fullerene-fused tetrahydroisoquinolines. In the presence of a Brønsted acid [60]fullerene-fused tetrahydroisoquinolines are transformed to [60]fullerene-fused indanes, in which the sulfonamide group can be removed or replaced with an aryl group.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA